Stockholm, September 21, 2017 — Nasdaq (Nasdaq: NDAQ) announces that the trading in SenzaGen AB’s shares (short name: SENZA) commenced today on Nasdaq First North in Stockholm. SenzaGen belongs to the health care sector and is the 76th company to be admitted to trading on Nasdaq’s Nordic markets* in 2017.
Established as a spin out from Lund University, SenzaGen is a Swedish company with expertise in immunology, technology and genomics. The company offers animal-free testing of chemical compounds by using a so called genomics-based methodology for immunotoxicological assays. Its proprietary lead product family, GARD, potentially replaces the need for animal testing in the cosmetic, chemical and pharmaceutical industries. SenzaGen is headquartered in Lund, Sweden and has an additional office in the US. For more information, please visit www.senzagen.com.
“We are excited to join Nasdaq First North and are proud of the support from investors whom have trusted us and joined our journey as a listed company,” said Anki Malmborg Hager, CEO of SenzaGen. “The listing and capital injection will allow us to continue the development and to forcefully execute our goals to deliver animal-free testing.”
“We welcome SenzaGen to our European growth market, Nasdaq First North,” said Adam Kostyál, SVP and Head of European listings at Nasdaq. “SenzaGen operates in an exciting field and we look forward to supporting them for many years to come.”
SenzaGen AB has appointed FNCA Sweden AB as the Certified Adviser.
*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
About Nasdaq First North
Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: http://business.nasdaq.com
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
|Media Relations Contact|
|+46 73 449 78 07|